scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Juliana Reis Machado | Q89266881 |
P2093 | author name string | Virmondes Rodrigues | |
Carlo Jose Freire Oliveira | |||
Marcos Vinicius da Silva | |||
Denise Bertulucci Rocha Rodrigues | |||
Monique Gomes Salles Tiburcio | |||
Djalma Alexandre Alves Silva | |||
P2860 | cites work | Recruitment of Mycobacterium tuberculosis specific CD4+ T cells to the site of infection for diagnosis of active tuberculosis. | Q39299211 |
Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung | Q39319543 | ||
ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection | Q39373309 | ||
The effect of interleukin-10 on apoptosis in macrophages stimulated by oxLDL. | Q39597464 | ||
The role of interleukin-10 in the inhibition of T-cell proliferation and apoptosis mediated by parainfluenza virus type 3. | Q39875341 | ||
T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. | Q40076818 | ||
Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations | Q40541640 | ||
Levels of interferon-gamma and interleukin-2 receptor-alpha for bronchoalveolar lavage fluid and serum were correlated with clinical grade and treatment of pulmonary tuberculosis | Q40577536 | ||
Interleukin-10 receptor signaling through STAT-3 regulates the apoptosis of retinal ganglion cells in response to stress | Q40613314 | ||
Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis. | Q40813543 | ||
Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-gamma and in interleukin-4-expressing cells | Q41471673 | ||
IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection. | Q41764389 | ||
Patients with multidrug-resistant tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an outbreak of multidrug-resistant Mycobacterium tuberculosis M and Ra strains | Q41961229 | ||
An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells | Q42139586 | ||
Progression of clinical tuberculosis is associated with a Th2 immune response signature in combination with elevated levels of SOCS3. | Q42226368 | ||
Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling | Q42416289 | ||
Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10. | Q42943512 | ||
T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation | Q42971196 | ||
IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo | Q42971329 | ||
Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders | Q42997948 | ||
Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis | Q44064936 | ||
Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis | Q44201389 | ||
Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis | Q44266163 | ||
Increased susceptibility of mice lacking T-bet to infection with Mycobacterium tuberculosis correlates with increased IL-10 and decreased IFN-gamma production | Q44354846 | ||
Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis | Q44390333 | ||
Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. | Q44453951 | ||
Depletion of IL-22 during culture enhanced antigen-driven IFN-γ production by CD4(+)T cells from patients with active TB. | Q45246028 | ||
Negative and Positive Predictive Value of a Whole-Blood Interferon-γ Release Assay for Developing Active Tuberculosis | Q46093848 | ||
Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis | Q46431604 | ||
Increased specific T cell cytokine responses in patients with active pulmonary tuberculosis from Central Africa | Q46502655 | ||
Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production. | Q47694485 | ||
T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis. | Q47969507 | ||
Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines | Q48245059 | ||
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. | Q21034169 | ||
Interleukin-10 and the interleukin-10 receptor | Q24290912 | ||
Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling | Q24625230 | ||
Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5 | Q24635387 | ||
Update on latent tuberculosis infection | Q26828541 | ||
A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo | Q27349862 | ||
IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells | Q28590243 | ||
Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity | Q29042353 | ||
Interaction between HIV and Mycobacterium tuberculosis | Q29397094 | ||
Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages | Q29547420 | ||
Immunology of tuberculosis | Q29614370 | ||
Differentiation of effector CD4 T cell populations (*) | Q29614838 | ||
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection | Q29616521 | ||
Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages | Q29617356 | ||
A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
Disseminated tuberculosis in interferon gamma gene-disrupted mice | Q29619812 | ||
Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses | Q29619908 | ||
Regulatory T cells: mechanisms of differentiation and function | Q29620731 | ||
Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones | Q29622840 | ||
Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice | Q29622922 | ||
Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. | Q30438825 | ||
Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from recent exposure in The Gambia | Q30828531 | ||
Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment | Q33265416 | ||
The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle | Q33339582 | ||
CCR6 is expressed on an IL-10-producing, autoreactive memory T cell population with context-dependent regulatory function | Q33730136 | ||
Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice. | Q33748060 | ||
Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. | Q50671032 | ||
Development of miliary tuberculosis related to anti-tumor necrosis factor-alpha inhibitor therapy for pustular psoriasis. | Q50941807 | ||
Keeping STATs on memory CD8+ T cells. | Q50981205 | ||
Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. | Q51316721 | ||
Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. | Q51824660 | ||
Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis. | Q51838282 | ||
Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients. | Q51971728 | ||
IL-10 is required for optimal CD8 T cell memory following Listeria monocytogenes infection. | Q51980500 | ||
Characterization of the memory/activated T cells that mediate the long-lived host response against tuberculosis after bacillus Calmette-Guérin or DNA vaccination. | Q52032470 | ||
Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. | Q52534366 | ||
Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3. | Q52927400 | ||
Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12. | Q52927700 | ||
Increased Th1 and Th2 type cytokine production in patients with active tuberculosis. | Q53025059 | ||
Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. | Q53446140 | ||
Profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis. | Q53668976 | ||
Therapy of tuberculosis in mice by DNA vaccination. | Q54085325 | ||
Autoimmune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin. | Q54198243 | ||
Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens | Q56828019 | ||
CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses | Q56904642 | ||
In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha | Q57339973 | ||
Depressed T‐Cell Interferon‐γ Responses in Pulmonary Tuberculosis: Analysis of Underlying Mechanisms and Modulation with Therapy | Q58329499 | ||
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge | Q58518610 | ||
Type 2 Cytokine Gene Activation and Its Relationship to Extent of Disease in Patients with Tuberculosis | Q58826841 | ||
Restoration of mycobacterial antigen-induced proliferation and interferon-γ responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy | Q58827836 | ||
IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi | Q58843169 | ||
Inactivation of CD4+ CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load | Q59050560 | ||
CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients | Q61885691 | ||
Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production | Q70527759 | ||
Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis | Q71764410 | ||
T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection | Q71929941 | ||
Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions | Q72896100 | ||
Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities | Q73556652 | ||
Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement | Q73626386 | ||
IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii | Q73755946 | ||
IL-4, IL-5 and IL-10 are not required for the control of M. bovis-BCG infection in mice | Q74467274 | ||
Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy | Q77204273 | ||
Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis | Q77399349 | ||
Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis | Q77437186 | ||
Sequestration of T lymphocytes to body fluids in tuberculosis: reversal of anergy following chemotherapy | Q77828348 | ||
Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis | Q78687288 | ||
Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection | Q79929535 | ||
IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis | Q79933186 | ||
Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis | Q80391038 | ||
Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: activation of CD8+ cells, interferon-gamma recovery and reduction of lung injury | Q80454652 | ||
Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression | Q80523271 | ||
Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells | Q82282261 | ||
A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis | Q82853651 | ||
Differential regulation of Notch ligands in dendritic cells upon interaction with T helper cells | Q83477958 | ||
T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients | Q83816784 | ||
IL-10 inhibits apoptosis and microvesiculation of human monocytes | Q84166116 | ||
DNA vaccines | Q93896322 | ||
IL-4 in tuberculosis: implications for vaccine design | Q35868740 | ||
What's good for the host is good for the bug. | Q36057658 | ||
TNF-blocking agents and tuberculosis: new drugs illuminate an old topic | Q36059141 | ||
Notch controls the magnitude of T helper cell responses by promoting cellular longevity. | Q36061611 | ||
Heat-shock proteins induce T-cell regulation of chronic inflammation | Q36085622 | ||
IL-2 simultaneously expands Foxp3+ T regulatory and T effector cells and confers resistance to severe tuberculosis (TB): implicative Treg-T effector cooperation in immunity to TB. | Q36142227 | ||
DNA vaccines: progress and challenges | Q36186005 | ||
CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis | Q36229713 | ||
Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. | Q36229731 | ||
Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset | Q36277359 | ||
High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. | Q36362685 | ||
IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination | Q36375426 | ||
The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice | Q36376221 | ||
Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response | Q36416118 | ||
Notch regulates IL-10 production by T helper 1 cells | Q36491342 | ||
Immune factors and immunoregulation in tuberculosis | Q36673984 | ||
Natural regulatory T cells: mechanisms of suppression | Q36719995 | ||
T(H)1 cells control themselves by producing interleukin-10. | Q36831662 | ||
Innate and adaptive immunity through autophagy | Q36896712 | ||
Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells | Q37137636 | ||
Resident Th1-like effector memory cells in pulmonary recall responses to Mycobacterium tuberculosis | Q37273816 | ||
BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis | Q37316205 | ||
DNA vaccine containing the mycobacterial hsp65 gene prevented insulitis in MLD-STZ diabetes. | Q37368644 | ||
IL-21 mediates suppressive effects via its induction of IL-10. | Q37373090 | ||
Th1-Th2 polarisation and autophagy in the control of intracellular mycobacteria by macrophages. | Q37463450 | ||
Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children | Q37545011 | ||
Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. | Q37866633 | ||
The role of Notch in the differentiation of CD4⁺ T helper cells | Q38015257 | ||
The immune response in tuberculosis | Q38091698 | ||
Risk of tuberculosis infection in anti-TNF-α biological therapy: from bench to bedside | Q38111161 | ||
Autophagy as an immune effector against tuberculosis | Q38116134 | ||
In search of a new paradigm for protective immunity to TB | Q38192925 | ||
Chromatin-level regulation of the IL10 gene in T cells. | Q38337531 | ||
Identification of Mycobacterium tuberculosis-specific Th1, Th17 and Th22 cells using the expression of CD40L in tuberculous pleurisy | Q33916768 | ||
IL-10 production by CD4+ effector T cells: a mechanism for self-regulation | Q33927028 | ||
Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation | Q33996487 | ||
Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis | Q34002304 | ||
Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology | Q34006525 | ||
Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis | Q34008352 | ||
Akt regulates IL-10 mediated suppression of TNFα-induced cardiomyocyte apoptosis by upregulating Stat3 phosphorylation | Q34031817 | ||
Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis | Q34044493 | ||
Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. | Q34127776 | ||
Differentiation and recruitment of Th9 cells stimulated by pleural mesothelial cells in human Mycobacterium tuberculosis infection | Q34171286 | ||
Mycobacterium bovisBCG-Specific Th17 Cells Confer Partial Protection againstMycobacterium tuberculosisInfection in the Absence of Gamma Interferon | Q34177268 | ||
Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells | Q34235308 | ||
Different patterns of cytokines and chemokines combined with IFN-γ production reflect Mycobacterium tuberculosis infection and disease | Q34427734 | ||
Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis | Q34431001 | ||
IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available | Q34432140 | ||
Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10. | Q34435508 | ||
Type 1 T regulatory cells. | Q34448429 | ||
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity | Q34529549 | ||
Genetic dissection of immunity to mycobacteria: the human model | Q34542276 | ||
Multiplex analysis of cytokines/chemokines as biomarkers that differentiate healthy contacts from tuberculosis patients in high endemic settings | Q34581606 | ||
Innate immunity to Mycobacterium tuberculosis | Q34587177 | ||
IL-22 is mainly produced by IFNγ-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection | Q34608524 | ||
Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells | Q34609504 | ||
Clonal expansions of CD8+ T cells with IL-10 secreting capacity occur during chronic Mycobacterium tuberculosis infection | Q34615073 | ||
Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management | Q34648346 | ||
TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology | Q34712326 | ||
T Cell Activation and Proinflammatory Cytokine Production in Clinically Cured Tuberculosis Are Time-Dependent and Accompanied by Upregulation of IL-10. | Q34793513 | ||
Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose | Q34995059 | ||
Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections | Q35205539 | ||
T-cell cytokine responses in human infection with Mycobacterium tuberculosis | Q35433339 | ||
Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection | Q35441389 | ||
Absence of a prominent Th2 cytokine response in human tuberculosis | Q35483311 | ||
Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis | Q35563366 | ||
IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection | Q35737807 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Mycobacterium tuberculosis | Q130971 |
cytokine | Q212354 | ||
tuberculosis | Q12204 | ||
helper-inducer T-lymphocytes | Q65983548 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 639107 | |
P577 | publication date | 2015-10-01 | |
P1433 | published in | Journal of Immunology Research | Q26841936 |
P1476 | title | Complexity and Controversies over the Cytokine Profiles of T Helper Cell Subpopulations in Tuberculosis | |
P478 | volume | 2015 |
Q92450932 | 7-oxo-DHEA enhances impaired M. tuberculosis-specific T cell responses during HIV-TB coinfection |
Q64239886 | Asthma and atopy prevalence are not reduced among former tuberculosis patients compared with controls in Lima, Peru |
Q40325377 | CD137 is a Useful Marker for Identifying CD4+ T Cell Responses to Mycobacterium tuberculosis |
Q52595107 | Cordyceps sinensis may inhibit Th22 cell chemotaxis to improve kidney function in lgA nephropathy. |
Q38751464 | DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine |
Q91868702 | Harnessing the Immunomodulatory Properties of Bacterial Ghosts to Boost the Anti-mycobacterial Protective Immunity |
Q64102170 | Mycobacteria-Specific T Cells May Be Expanded From Healthy Donors and Are Near Absent in Primary Immunodeficiency Disorders |
Q37633072 | Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa |
Q39437320 | Striking the right immunological balance prevents progression of tuberculosis |
Q33590366 | Suppressors of cytokine signaling in tuberculosis |
Search more.